• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.

作者信息

Zhang Yongbo, Li Peizhen, Yin Yuhan, Li Fuqiang, Zhang Qinghua

机构信息

Department of Respiratory Medicine, An Qiu People's Hospital, Anqiu, China.

Department of Clinical Laboratory, Liao Cheng Dong Chang Fu People's Hospital, Liaocheng, China.

出版信息

J Antibiot (Tokyo). 2017 Feb;70(2):193-195. doi: 10.1038/ja.2016.93. Epub 2016 Jul 27.

DOI:10.1038/ja.2016.93
PMID:27460764
Abstract
摘要

相似文献

1
In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates.替加环素联合利福平、多黏菌素或头孢他啶对耐碳青霉烯类肺炎克雷伯菌血流分离株的体外活性
J Antibiot (Tokyo). 2017 Feb;70(2):193-195. doi: 10.1038/ja.2016.93. Epub 2016 Jul 27.
2
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.多利培南单独及联合用药对广泛耐药鲍曼不动杆菌和肺炎克雷伯菌的体外活性。
Diagn Microbiol Infect Dis. 2013 Jul;76(3):343-6. doi: 10.1016/j.diagmicrobio.2013.03.014. Epub 2013 Apr 17.
3
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.碳青霉烯类耐药肺炎克雷伯菌的治疗：现状。
Expert Rev Anti Infect Ther. 2013 Feb;11(2):159-77. doi: 10.1586/eri.12.162.
4
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.黏菌素联合其他抗菌药物对耐黏菌素产KPC肺炎克雷伯菌血流分离株的体外活性及抗生素后效应
J Antimicrob Chemother. 2014 Jul;69(7):1856-65. doi: 10.1093/jac/dku065. Epub 2014 Mar 19.
5
Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.外排泵抑制剂在印度北部一家三级医院降低肺炎克雷伯菌抗生素耐药性中的作用
J Infect Dev Ctries. 2015 Aug 29;9(8):815-20. doi: 10.3855/jidc.6216.
6
Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?米诺环素和替加环素：它们在治疗耐碳青霉烯革兰氏阴性菌方面的作用是什么？
Microb Drug Resist. 2017 Jun;23(4):437-446. doi: 10.1089/mdr.2016.0043. Epub 2016 Aug 26.
7
[Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].[控制烧伤患者中耐碳青霉烯类肺炎克雷伯菌的感染与传播]
Zhonghua Shao Shang Za Zhi. 2015 Feb;31(1):5-8.
8
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.多黏菌素 B、利福平与多利培南对多重耐药鲍曼不动杆菌、铜绿假单胞菌、肺炎克雷伯菌和大肠埃希菌体外联合杀菌活性研究
Antimicrob Agents Chemother. 2010 Jun;54(6):2732-4. doi: 10.1128/AAC.01768-09. Epub 2010 Apr 5.
9
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.单独使用或与多黏菌素联用的各种抗生素对重症监护病房分离的肺炎克雷伯菌菌株的影响。
Biomed Res Int. 2014;2014:397421. doi: 10.1155/2014/397421. Epub 2014 Oct 28.
10
Mutant prevention concentration of tigecycline for Klebsiella pneumoniae isolates with four different resistance statuses.替加环素对四种不同耐药状态的肺炎克雷伯菌分离株的突变预防浓度。
J Infect Dev Ctries. 2015 Oct 29;9(10):1177-9. doi: 10.3855/jidc.7156.

引用本文的文献

1
Activity of cefiderocol in combination with tetracycline analogues against carbapenem-resistant Acinetobacter baumannii.头孢地尔与四环素类似物联合使用对耐碳青霉烯类鲍曼不动杆菌的活性。
J Antibiot (Tokyo). 2025 Feb;78(3):190-196. doi: 10.1038/s41429-024-00801-8. Epub 2024 Dec 23.
2
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.

本文引用的文献

1
In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.磷霉素与黏菌素联合对耐碳青霉烯类铜绿假单胞菌临床分离株的体外活性
J Antibiot (Tokyo). 2015 Sep;68(9):551-5. doi: 10.1038/ja.2015.27. Epub 2015 Mar 25.
2
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.单独使用或与多黏菌素联用的各种抗生素对重症监护病房分离的肺炎克雷伯菌菌株的影响。
Biomed Res Int. 2014;2014:397421. doi: 10.1155/2014/397421. Epub 2014 Oct 28.
3
Combination therapy for carbapenem-resistant Gram-negative bacteria.
碳青霉烯类耐药革兰氏阴性菌的联合治疗。
J Antimicrob Chemother. 2014 Sep;69(9):2305-9. doi: 10.1093/jac/dku168. Epub 2014 May 28.
4
Combination therapy for carbapenem-resistant Gram-negative bacteria.碳青霉烯类耐药革兰氏阴性菌的联合治疗。
Expert Rev Anti Infect Ther. 2013 Dec;11(12):1333-53. doi: 10.1586/14787210.2013.845523. Epub 2013 Nov 6.
5
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.碳青霉烯类耐药肠杆菌科细菌感染的抗生素治疗：现有证据的系统评价。
Antimicrob Agents Chemother. 2014;58(2):654-63. doi: 10.1128/AAC.01222-13. Epub 2013 Sep 30.
6
Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.替加环素联合黏菌素、美罗培南、利福平或庆大霉素对产KPC肠杆菌科细菌在小鼠大腿感染模型中的活性。
Antimicrob Agents Chemother. 2013 Dec;57(12):6028-33. doi: 10.1128/AAC.00891-13. Epub 2013 Sep 23.
7
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.全球扩展型碳青霉烯酶肺炎克雷伯菌的临床流行病学。
Lancet Infect Dis. 2013 Sep;13(9):785-96. doi: 10.1016/S1473-3099(13)70190-7.
8
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.肺炎克雷伯菌和其他肠杆菌科细菌中的碳青霉烯酶：具有全球范围的不断演变的危机。
Clin Microbiol Rev. 2012 Oct;25(4):682-707. doi: 10.1128/CMR.05035-11.
9
Pharmacokinetic and pharmacodynamic evaluation of tigecycline.替加环素的药代动力学和药效学评价。
Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1459-70. doi: 10.1517/17425255.2011.623126. Epub 2011 Sep 30.
10
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis.替加环素治疗感染性疾病的疗效和安全性：一项荟萃分析。
Lancet Infect Dis. 2011 Nov;11(11):834-44. doi: 10.1016/S1473-3099(11)70177-3. Epub 2011 Jul 23.